Effect of tonsillectomy on ASO titre

Abstract

Background: Tonsillitis is one of the common clinical problems in Otolaryngology practice. Tonsillectomy is the preferable treatment for patients not responding to medical treatment. Many patients have increased Antistreptolysin O (ASO) titres which is caused by Group A Beta Hemolytic Streptococci (GABHS). 

Objectives: To determine the effect of tonsillectomy on ASO titre.

Materials and Methods:  A prospective study conducted in the Department of Otorhinolaryngology, Regional Institute of Medical Sciences, Imphal, Manipur, India for a period of 2 years from October 2014 to September 2016. 50 patients diagnosed as recurrent tonsillitis with raised ASO titre above 200 IU/ml and undergoing tonsillectomy were enrolled for the study. 

Results: Most of the patients were in the age group of 11-15 years with male to female ratio  of 1: 1.63. One month after tonsillectomy 11 (22%) patients were negative for ASO titre. After 3 months, 6 months and 1 year follow up, patients whose ASO titre became negative were 34 (68%), 44 (88%) and 45 (90%) respectively. 72% patients had no episodes of sore throat after tonsillectomy.

Conclusion: Tonsillectomy has a significant role in preventing or reducing recurrent streptococcal throat infections.

Keywords:

Tonsillectomy, ASO titre, Sore throat, Tonsillitis

References

Kvested E, Kvalrner KJ, Rocysamb E, Tambs K, Harris JR, Magner P. Division of epidemiology, Norwegian Institute of Public Health. Arch Otolaryngol Head Neck Surg. 2005;131:383–7.

Viswanathan N, Sasikumaran S, Thulaseedharan S. Effect of tonsillectomy on ASO-titre. Ind J Otolaryngol Head Neck Surg. 2000;52(4):329-31.

Hembrom R, Roychaudhuri BK, Saha AK, Roychowdhury A, Ghosh S, Gon S et al. Evaluation of the validity of high serum antistreptolysin O titre only, as an indication for tonsillectomy. Ind J Otolaryngol Head Neck Surg. 2014;66(3):232-6.

Kaplan EL, Rothermal CD, Johnson DR. Antistreptolysin O and anti-deoxyribonuclease B titres: normal values for children ages 2 to 12 in the United States. Pediatr. 1998;101(1 Pt1):86-8.

Paradise JL, Bluestone CD, Bachman RZ. Efficacy of tonsillectomy for recurrent throat infection in severely affected children. Results of parallel randomized and nonrandomized clinical trials. N Engl J Med. 1984;310(11):674-83.

El-magd EAA, Meguid MA, Tahan AERE. The value of high antistreptolysin O titre as an indicator of tonsillectomy in Upper Egypt. Int J Otolaryngol Head Neck Surg. 2016;5(1):1-5.

Mohammed MS. Streptococcal throat infection among Yemeni children. Iraqi J Sci. 2009;50(1):126-35.

Fujikawa S, Hanawa Y, Ito Y, Ohkuni M, Todome Y, Ohkuni H. Streptococcal antibody: as an indicator of tonsillectomy. Acta Otolaryngology. 1988;454(8):286-91.

Robert C, Charles HR, Lewis WW, Floyd WD. The effect of tonsillectomy on the incidence of streptococcal respiratory disease and its complications. Pediatr. 1960;26(3):355-67.

Motonski GM. Epidemiology of streptococcal infections in rheumatic and non rheumatic families. Am J Epidemiology. 1968;87(2):226-7.

Lock C, Wilson J, Steen N, Eccles M, Mason H, Carrie S et al. North of England and Scotland study of tonsillectomy and adeno-tonsillectomy in children (NESSTAC): a pragmatic randomised controlled trial with a parallel non-randomised preference study. Health Technol Assess. 2010;14(13):1-164.